🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bhumsuk Keam

Seoul National University

ORCID: 0000-0001-8196-4247

Also affiliated with Seoul National University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study”.

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Annals of Oncology(2022)10.1016/j.annonc.2021.12.014
N/A
7.1DataRank · unranked
352 citations

Robert J. Kreitman, Zev A. Wainberg, Y. Choi, Jan H.M. Schellens, Jean‐Charles Soria +9 more

Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?

The Korean Journal of Internal Medicine(2019)10.3904/kjim.2017.397
N/A
0.434DataRank · unranked
17 citations

Chan-Young Ock, Bhumsuk Keam, Sung Joon Park, Tae Min Kim, Jin Ho Kim +11 more

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2021)10.1172/jci150335
N/A
0DataRank · unranked
60 citations

Bhumsuk Keam, Janice Cho, Michelle J. Lee, Hye Ryun Kim, Hayarpi Torosyan +16 more

Data from Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma

(2023)10.1158/0008-5472.c.6512485.v1
N/A
0DataRank · unranked
0 citations

Hyun‐Su Kim, Brandon Leonard, Shizhang Ling, Bhumsuk Keam, Luigi Marchionni +7 more

The Small Molecule Inhibitor of the Wnt–β‐Catenin Pathway, CWP232291 , Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma

Head & Neck(2025)10.1002/hed.28249
N/A
0DataRank · unranked
1 citations

Bhumsuk Keam, Hyun-Su Kim, Leilani Jones, Brandon Leonard, Anita Pothukuchi +5 more

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1030
N/A
0DataRank · unranked
26 citations

Myung‐Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong +9 more

Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma

Cancer Research(2021)10.1158/0008-5472.can-20-1780
N/A
0DataRank · unranked
20 citations

Hyun-Su Kim, Brandon Leonard, Shizhang Ling, Bhumsuk Keam, Luigi Marchionni +7 more